Ayurvedic Management of Pelvic Inflammatory Disease and Associated Reproductive Disorders to Conception: A Retrospective Case Series of 30 Women

Background: Pelvic inflammatory disease (PID) is a major cause of reproductive morbidity, contributing to tubal scarring, infertility, ectopic pregnancy, and chronic pelvic pain. Conventional management relies on antimicrobial therapy, yet some women experience persistent symptoms or residual reproductive complications. Ayurveda conceptualises such disorders within the framework of Yoni Vyapat and employs individualised, multimodal interventions; however, clinical evidence in real-world PID populations remains limited. Methods: This retrospective case series describes 30 women (aged 20–40 years) with PID and associated reproductive disorders (habitual abortion, PCOD, tubal pathology, TORCH positivity, ovulatory disturbances) who received individualised Ayurvedic management at a single centre. The core protocol included Tablet Poshini (fertility support), Tablet Upaja (ovulatory and menstrual regulation), and Tablet Jivani (infective/inflammatory component), with additional condition-specific medicines as indicated. Additional Ayurvedic medicines were prescribed individually according to the patient’s associated gynecological and reproductive conditions, clinical presentation, and treatment requirements. Treatment duration ranged from 2 to 16 months. Clinical characteristics, associated conditions, and treatment parameters were extracted from case records. Time to conception was defined as the interval between initiation of Ayurvedic treatment and documented conception. Results: All patients had clinically documented PID, with associated conditions including habitual abortion, PCOD, tubal blockage, hydrosalpinx, anovulatory cycles, delayed menstruation, TORCH positivity, and other pelvic or reproductive abnormalities. All 30 women achieved conception during the documented follow-up period, with time to conception ranging from 2 to 16 months. The individualized treatment approach addressed fertility support, ovulatory function, and infective/inflammatory concerns according to individual clinical needs.